The Europe biobanking market size surpassed USD 24.99 billion in 2025 and is predicted to reach around USD 60.81 billion by 2035, registering a CAGR of 9.3% from 2026 to 2035. The market is mainly driven by the rising personalized medicine, greater research and development in genomics and stem cell studies, and strong investment in healthcare infrastructure.

Europe Biobanking Market Statical Scope

The market is essential for promoting personalized medicine, accelerating drug discovery, and enhancing biomedical research by safely storing, managing, and analyzing biological samples such as DNA, tissue, and blood. It commands a significant portion of the global market due to high-quality population studies and the widespread use of automated technologies.

Europe is at the forefront of population-based biobanking , linking genetic information with environmental factors to better understand chronic diseases. Initiatives like the European Research Infrastructure Consortium (BBMRI-ERIC) set high standards for sample management, allowing researchers from different countries to share data and samples. The market is quickly changing with advancements in AI, IoT -enabled systems, and automated cryogenic cold storage, which help maintain sample integrity and enhance research efficiency.

Europe Biobanking Market Share, By Sample Storage, 2025 (%)

• Blood - Accounting for 52% of the market, the blood segment is vital to the European biobanking industry, leading in market share in 2025. Its dominance stems from blood being a versatile, easily accessible, and non-invasive source of genetic material and biomarkers that are crucial for precision medicine, extensive population studies, and pharmaceutical research.
• Cells & Tissues - Holding a 35% share, the Cells & Tissues segment is essential in the European biobanking market due to its significant role in advanced regenerative medicine, precision oncology, and the investigation of complex, age-related diseases. As Europe leads globally in biobanking, there is a growing demand for high-quality human tissues and stem cells from both academic institutions and pharmaceutical companies.

Europe Biobanking Market Share, By Application, 2025 (%)

• Regenerative Medicines - The regenerative medicine segment, which holds a 47% share, is the leading application in biobanking. It is a critical, rapidly growing area within the European biobanking market, serving as the main supplier of specialized, high-viability biological materials needed for advanced therapies such as stem cell treatment, tissue engineering, and gene therapy.
• Life Science - With a 43% share, the Life Science segment is the key driver in the European biobanking market, primarily because it connects academic research, drug discovery, and clinical application. The Life Science sector utilizes these repositories to obtain high-quality, standardized samples essential for developing personalized medicines.

Europe Biobanking Market Share, By Settings, 2025 (%)

• Academic Medical Institutions - With a 42% share, the Academic Medical Institutions segment plays a crucial role in the European Biobanking Market as it is the main provider of high-quality, ethically sourced biospecimens and clinical data necessary for translational research and personalized medicine. These institutions are the backbone of biomedical research, connecting patient care with scientific discovery.
• Pharmaceutical & Biotechnological Companies - Holding a 48% share, the Pharmaceutical & Biotechnological Companies segment leads the European biobanking market, driving progress in precision medicine, drug discovery, and personalized therapies. This segment is vital for the market's growth, especially in facilitating the swift development of cell and gene therapy pipelines.

Top Companies in the Europe Biobanking Market

• Thermo Fisher Scientific Inc.
• Tecan Trading AG
• QIAGEN
• Hamilton Company
• Brooks Life Sciences
• TTP Labtech
• VWR International, LLC.
• Promega Corporation
• Worthington Industries
• BD
• Merck KGaA
• Biokryo GmbH
• Cell&Co BioServices
• RUCDR Infinite Biologics
• Modul-Bio

Segments Covered in the Report

By Sample Storage

• Blood
• Cells & Tissues
• Others

By Application

• Regenerative Medicines
• Life Science
• Others

By Settings

• Academic Medical Institutions
• Pharmaceutical & Biotechnological Companies